Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $35.17 USD
Change Today +0.52 / 1.50%
Volume 118.0K
BRLI On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

bio-reference labs inc (BRLI) Snapshot

Open
$34.58
Previous Close
$34.65
Day High
$35.28
Day Low
$34.42
52 Week High
03/24/15 - $36.75
52 Week Low
05/15/14 - $24.19
Market Cap
976.9M
Average Volume 10 Days
261.7K
EPS TTM
--
Shares Outstanding
27.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIO-REFERENCE LABS INC (BRLI)

bio-reference labs inc (BRLI) Related Bloomberg News

View More Bloomberg News

bio-reference labs inc (BRLI) Related Businessweek News

No Related Businessweek News Found

bio-reference labs inc (BRLI) Details

Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases in the United States. The company focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional health care services. It offers chemical diagnostic tests, such as blood and urine analysis; blood chemistry; hematology services; serology; radio-immuno analysis; toxicology, including drug screening; pap smears; tissue pathology comprising biopsies; and other tissue analysis, as well as cancer cytogenetic testing, genetic testing, and cytology testing services. The company also operates a clinical knowledge management service unit, which uses customer data from laboratory results, pharmaceutical data, claims data, and other data sources to provide administrative and clinical decision support systems; and a Web-based connectivity portal solution for laboratories and physicians. It serves physicians, geneticists, hospitals, clinics, and correctional and other health facilities. The company was founded in 1981 and is headquartered in Elmwood Park, New Jersey.

3,406 Employees
Last Reported Date: 01/13/15
Founded in 1981

bio-reference labs inc (BRLI) Top Compensated Officers

Founder, Chairman, Chief Executive Officer, P...
Total Annual Compensation: $1.2M
Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $457.3K
Chief Operating Officer, Executive Vice Presi...
Total Annual Compensation: $457.3K
Compensation as of Fiscal Year 2014.

bio-reference labs inc (BRLI) Key Developments

Bio-Reference Laboratories, Inc. Announces Executive Changes

On March 3, 2015, Sam Singer, the chief financial officer of Bio-Reference Laboratories Inc. informed the board of directors that he intends to retire from such position effective as of April 30, 2015. Mr. Singer will continue to serve as a director of the company. On March 3, 2015, the board of directors appointed Nicholas Papazicos to serve as the company's chief financial officer effective as of April 30, 2015. Most recently, Mr. Papazicos has served as senior vice president of financial operations since June 2012. On March 3, 2015, the board of directors appointed Ilan Kaufthal to fill a vacancy on the board of directors created by the passing of Gary Lederman. Mr. Kaufthal currently services on the boards of directors of Cambrex Corporation. Mr. Kaufthal also serves on the advisory board of Jerusalem Venture Partners Media Fund and is a trustee of the Russell Berrie Foundation. Mr. Kaufthal will be designated a Class III Director as was Mr. Lederman and will be up for election at the 2015 annual meeting of stockholders. He was appointed to serve as chairman of the compensation committee and nominating and corporate governance committee and will serve as a member of the audit committee.

Bio-Reference Laboratories Inc. Reports Unaudited Earnings Results for the First Quarter Ended January 31, 2015; Reaffirms Earnings Outlook for the Year 2015

Bio-Reference Laboratories Inc. reported unaudited earnings results for the first quarter ended January 31, 2015. For the period, the company’s net revenues were $208,833,000 against $181,270,000 a year ago. Operating income was $11,928,000 against $5,880,000 a year ago. Income before tax was $11,504,000 against $5,255,000 a year ago. Net income was $6,633,000 against $2,954,000 a year ago. Income per share was $0.24 against $0.11 a year ago. Cash flow for the quarter was just over $10 million, cash flow from operations was an improvement over a positive cash flow in the fourth quarter the previous year. Free cash flow was just shy of $4.3 million. The company reaffirmed its annual guidance of at least 10% growth in net revenues and 20% growth in net earnings.

Bio-Reference Laboratories Inc. to Report Q1, 2015 Results on Mar 05, 2015

Bio-Reference Laboratories Inc. announced that they will report Q1, 2015 results at 10:30 AM, US Eastern Standard Time on Mar 05, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRLI:US $35.17 USD +0.52

BRLI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Foundation Medicine Inc $47.97 USD -0.09
Genomic Health Inc $30.21 USD +0.55
Myriad Genetics Inc $35.76 USD +0.21
NeoGenomics Inc $4.72 USD 0.00
Sequenom Inc $3.90 USD +0.08
View Industry Companies
 

Industry Analysis

BRLI

Industry Average

Valuation BRLI Industry Range
Price/Earnings 19.4x
Price/Sales 1.1x
Price/Book 3.0x
Price/Cash Flow 12.8x
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-REFERENCE LABS INC, please visit www.bioreference.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.